Praxis Precision Medicines, Inc. (PRAX)

NasdaqGS • Currently down 3.34 (-0.94%) in today's trading session

1 member of Congress has disclosed 1 trade in Praxis Precision Medicines, Inc. (PRAX) via STOCK Act filings. The most recent disclosure was a purchase by Gilbert Cisneros on 30 July 2026. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).

Praxis Precision Medicines, Inc. is currently trading at $351.81, positioned at 88% of its 52-week range ($37.19 – $392.70).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$351.81
24h Change
-3.34 (-0.94%)
52 Week Range
$37.19–$392.70
View on NASDAQ

Praxis Precision Medicines, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for PRAX

Select to highlight on chart
1 transactions
Compliance: 100%
Gilbert Cisneros30 Jul 20264 Sept 2026PurchaseStock$1,001 - $15,000+20.88%

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$9.81B

Volume

175.36K

Beta

2.78

P/E Ratio

-27.21

Fundamentals

EPS

$-12.93

Div. Yield

-

Open

$352.99

Day Range

$349.82 – $357.49

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Marcio Silva De'Souza
IPO Date
2020-10-16
Website
www.praxismedicines.com

Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's prim...

Earnings

Next Report

Q3 2026

9 Nov

EPS Est.

$-3.65

Rev. Est.

$130.8K

Days Until

63

Recent Quarters

Q2 20266 Aug
EPS$-2.87
Beat 21.8%
Q1 20267 May
EPS$-3.20
Beat 10.6%
Q4 202519 Feb
EPS$-3.50
Miss 12.0%
Q3 20255 Nov
EPS$-3.36
Beat 2.6%
Q2 20254 Aug
EPS$-3.31
Beat 2.6%
Q1 20252 May
EPS$-3.29
Miss 2.8%
Q4 202428 Feb
EPS$-2.94
Miss 6.5%
Q3 20246 Nov
EPS$-2.75
Miss 36.8%
Q2 202413 Aug
EPS$-1.74
Beat 26.9%
Q1 202413 May
EPS$-2.84
Miss 41.3%
Q4 20235 Mar
EPS$-2.97
Beat 5.7%
Q3 20237 Nov
EPS$-2.70
Beat 48.6%
Q2 20239 Aug
EPS$-7.35
Beat 25.8%
Q1 202311 May
EPS$-10.64
Beat 5.3%
Q4 20227 Feb
EPS$-13.04
Miss 19.2%
Q3 20229 Nov
EPS$-14.39
Miss 4.3%
Q2 20228 Aug
EPS$-19.79
Miss 1.5%
Q1 20229 May
EPS$-22.64
Miss 17.1%
Q4 202128 Feb
EPS$-19.49
Miss 20.4%
Q3 20213 Nov
EPS$-14.99
Miss 7.5%
Q2 202116 Aug
EPS$-13.19
Miss 29.4%
Q1 202111 May
EPS$-10.64
Beat 4.1%
Q4 202017 Mar
EPS$-13.04
Miss 128.8%
Q3 202023 Nov
EPS$-12.10
Miss 1557.5%
Q3 202016 Oct
EPS$-105.64
Q4 201931 Mar
EPS$-76.69
Q3 201931 Dec
EPS$-68.71
Q2 201930 Sept
EPS$-101.99
Q1 201930 Jun
EPS$-100.35
Q4 201831 Mar
EPS$-100.35

No dividend data available for this stock.

Stock Splits

Split History

29 Nov 2023Reverse Split
Ratio1:15

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about PRAX

Which members of Congress have traded PRAX?
1 member of Congress has disclosed 1 trade in Praxis Precision Medicines, Inc. (PRAX) under the STOCK Act: Gilbert Cisneros.
When was PRAX most recently disclosed by Congress?
The most recent PRAX disclosure was a purchase by Gilbert Cisneros on 30 July 2026.
What is the total disclosed congressional trading volume for PRAX?
Members of Congress have disclosed approximately $8K in PRAX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in PRAX?
This PRAX page updates as soon as new STOCK Act disclosures are filed for Praxis Precision Medicines, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.